Eric Levesque, CPA, currently serves as the Director of Financial Planning and Analysis at Sionna Therapeutics, a position held since May 2024. Previously, Eric held various leadership roles in Financial Planning and Analysis at Rallybio from May 2022 to May 2024 and at Alexion Pharmaceuticals, Inc. from December 2015 to May 2022, where responsibilities ranged from Associate Director of Global Clinical Supply Planning to Senior Manager of R&D Accounting. Eric's career began at Hitachi Capital America Corp. as an Accountant, followed by positions at Louis Dreyfus Commodities. Educational qualifications include a Bachelor of Science in Accounting from Post University and a Bachelor of Science in Business Administration and Management from Roger Williams University.